Review
Jul 2026
Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors.
The historical milestones in ERK1/2 research are outlined, from their discovery and structural characterization to their identification as oncogenic drivers and therapeutic targets, and the potential of ERK1/2-targeted therapies in precision oncology is highlighted.
Zhi-Qi Peng, Yuqi Fu, Yanmei Chen et al.
· Medicinal research reviews (... · 0 citations